Mike Matson
Stock Analyst at Needham
(3.46)
# 955
Out of 5,093 analysts
533
Total ratings
47.22%
Success rate
4.61%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Buy | $148 → $166 | $136.60 | +21.52% | 14 | Dec 8, 2025 | |
| SYK Stryker | Reiterates: Buy | $448 | $353.60 | +26.70% | 10 | Nov 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.05 | +185.71% | 22 | Nov 13, 2025 | |
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $4.25 → $9 | $4.94 | +82.19% | 2 | Nov 11, 2025 | |
| HAE Haemonetics | Maintains: Buy | $68 → $78 | $83.21 | -6.26% | 15 | Nov 7, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $58 | $44.07 | +31.61% | 20 | Nov 7, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $48 → $70 | $71.18 | -1.66% | 4 | Nov 6, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $10 | $9.82 | +1.83% | 21 | Nov 5, 2025 | |
| VCYT Veracyte | Maintains: Buy | $41 → $44 | $44.36 | -0.81% | 18 | Nov 5, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $83.11 | +29.95% | 31 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $26 | $18.24 | +42.54% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $326 | $294.83 | +10.57% | 12 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $74.85 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $121 | $93.84 | +28.94% | 34 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.36 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $62.67 | +2.12% | 27 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $14 | $11.71 | +19.56% | 27 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $101.26 | - | 21 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $49 | $26.76 | +83.11% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $38.94 | +15.56% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $40.57 | +50.36% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.67 | +79.91% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $140.85 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $143.77 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $261.41 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $119.82 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $92.75 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $250.04 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $19.00 | +121.05% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $89.00 | -15.73% | 1 | Feb 18, 2021 |
TransMedics Group
Dec 8, 2025
Maintains: Buy
Price Target: $148 → $166
Current: $136.60
Upside: +21.52%
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $448
Current: $353.60
Upside: +26.70%
Lucid Diagnostics
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.05
Upside: +185.71%
Insight Molecular Diagnostics
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $4.94
Upside: +82.19%
Haemonetics
Nov 7, 2025
Maintains: Buy
Price Target: $68 → $78
Current: $83.21
Upside: -6.26%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $58
Current: $44.07
Upside: +31.61%
Establishment Labs Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $48 → $70
Current: $71.18
Upside: -1.66%
Personalis
Nov 5, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $9.82
Upside: +1.83%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $41 → $44
Current: $44.36
Upside: -0.81%
Merit Medical Systems
Oct 31, 2025
Reiterates: Buy
Price Target: $108
Current: $83.11
Upside: +29.95%
Oct 29, 2025
Maintains: Buy
Price Target: $42 → $26
Current: $18.24
Upside: +42.54%
Oct 27, 2025
Reiterates: Buy
Price Target: $326
Current: $294.83
Upside: +10.57%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $74.85
Upside: -
Oct 17, 2025
Reiterates: Buy
Price Target: $121
Current: $93.84
Upside: +28.94%
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.36
Upside: -
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $62.67
Upside: +2.12%
Aug 29, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $11.71
Upside: +19.56%
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $101.26
Upside: -
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $26.76
Upside: +83.11%
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $38.94
Upside: +15.56%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $40.57
Upside: +50.36%
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.67
Upside: +79.91%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $140.85
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $143.77
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $261.41
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $119.82
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $92.75
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $250.04
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $19.00
Upside: +121.05%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $89.00
Upside: -15.73%